Global settlement of pertuzumab biosimilar disputes across the U.S., UPC, the Netherlands and Brazil, highlighting Brazil’s key validity win and UPC order.

The Brazilian Court of Appeal has upheld a preliminary injunction for ZTE against Samsung, reinforcing patent exclusivity in 5G Standard Essential Patent disputes.

This BRPTO study analyzes 6,300 patent applications to map green innovation in Brazilian agriculture, highlighting biofertilizers and international cooperation.

Recent US lawsuits against AI meeting assistants highlight legal risks regarding voice data consent, offering crucial parallels for Brazil's LGPD framework.

O artigo analisa a Lei nº 15.325/2026 e a formalização do profissional multimídia no Brasil, destacando o reconhecimento jurídico e os desafios práticos.

Brazil’s Law 15,325/2026 recognizes multimedia professionals and influencers but faces criticism for educational requirements and lack of oversight mechanisms.

Learn how the Mercosur–EU agreement may reshape Brazil’s IP landscape, strengthening enforcement and influencing patents, trademarks, designs and trade secrets.

A comprehensive outlook on the 2026 regulatory landscape for Brazil's Life Sciences sector, covering CMED pricing, Anvisa's sandbox, and clinical trials.

The Brazilian Superior Court of Justice (STJ) clarifies the application of atypical coercive measures for monetary enforcement under Article 139, IV.

The EU Digital Omnibus simplifies GDPR and AI Act rules, shifting toward a risk-based approach to foster innovation while protecting fundamental data rights.

The BRPTO implements a structural reform under Decree #12,803/2025, focusing on technical specialization and governance to improve IP examination quality in Brazil.

Brazil implements new pricing criteria for technology transfer in Productive Development Partnerships (PDPs) to ensure transparency and SUS fiscal responsibility.

Brazil’s Ministry of Health's SUS Digital call repositions it as an innovation orchestrator, detailing institutional, legal, and IP implications for the HealthTech ecosystem.

Brazil's CMED introduces Rule No. 3/2025, modernizing drug pricing regulation by expanding categories, redefining therapeutic gain, and updating country references.

Brazil's 2025 SEP litigation experienced significant growth, with Rio courts becoming a key forum, marked by procedural innovations, FRAND emphasis, and emerging connected-car disputes.

The BRPTO suspended priority examination for H04 patent applications, effective January 1, 2026, a major shift for telecom and ICT patent prosecution in Brazil.

Brazil's new Private International Law Bill modernizes legal frameworks, focusing on foreign judgment enforcement and intellectual property rights, aiming to align the country with global legal standards and attract investment.

Brazil’s Ministry of Health and ABIFINA partnered on a patent-intelligence agreement to improve patent information use in the SUS, establishing a system akin to the US FDA’s Orange Book.

The article dissects the Apple-EU conflict over the Digital Markets Act, examining the regulation's implications for competition, security, and innovation in tech ecosystems.

The Mariana v. BHP case in the English High Court sets significant precedents for transnational environmental liability, applying Brazilian law to the Fundão Dam collapse.

Brazil's COP30 highlights industrial property's central role in fostering green innovation and a sustainable bioeconomy, crucial for climate leadership and equitable development.

The Brazilian Supreme Court reinterpreted Article 19 of the Civil Rights Framework, introducing a nuanced liability regime for digital platforms to address illegal content dissemination.

The Brazilian Patent Office's draft AI guidelines clarify patentability for AI-assisted inventions in biopharma and agrochemical sectors, emphasizing human contribution.